death rattle

From Aaushi
Jump to navigation Jump to search

Etiology

Pathology

Clinical manifestations

Complications

Management

More general terms

Additional terms

References

  1. 1.0 1.1 Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
    Geriatric Review Syllabus, 9th edition (GRS9) Medinal-Walpole A, Pacala JT, Porter JF (eds) American Geriatrics Society, 2016
    Geriatric Review Syllabus, 10th edition (GRS10) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2019
  2. 2.0 2.1 Protus BM, Grauer PA, Kimbrel JM. Evaluation of atropine 1% ophthalmic solution administered sublingually for the management of terminal respiratory secretions. Am J Hosp Palliat Care. 2013 Jun;30(4):388-92. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22833553
  3. 3.0 3.1 Shinjo T, Okada M. Atropine eyedrops for death rattle in a terminal cancer patient. J Palliat Med. 2013 Feb;16(2):212-3. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22747099
  4. 4.0 4.1 4.2 Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018
  5. 5.0 5.1 5.2 van Esch HJ, van Zuylen L, Geijteman ECT et al Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life. The SILENCE Randomized Clinical Trial. JAMA. 2021;326(13):1268-1276 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34609452 https://jamanetwork.com/journals/jama/fullarticle/2784661